Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Covance Receives SFDA GLP Certification | Contract Pharma

What are you searching for?

Sign in
Breaking News

Covance Receives SFDA GLP Certification

Shanghai facility provides early development services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Covance’s early development facility in Shanghai, China, has received GLP Certificate from the State Food and Drug Administration (SFDA) of the People’s Republic of China. The facility in Shanghai provides nonclinical safety assessment, bioanalytical, in vivo pharmacology, and DMPK services.
 
“Covance is now the only global CRO with SFDA GLP certification in China. Our early development facility in Shanghai offers world-class quality and expertise to companies with testing needs in China and the Asia Pacific region. Partnering with Covance in China will provide the gateway for local and regional pharmaceutical companies to access global markets and help save clients’ time and costs in their drug development process,” said Honggang Bi, corporate vice president and general manager, Covance China.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics